@FierceBiotech: MIT: Staggering cancer drugs can make them more effective. More | Follow @FierceBiotech
@RyanMFierce: It's only a matter of time before fat taxes are everywhere. Obesity costs too much, and taxes on smokes paved the way. Report | Follow @RyanMFierce
@JohnCFierce: Stealth no more: Ra Pharma in Cambridge nails $8.6M venture tranche, targets hereditary angioedema for the lead. Article | Follow @JohnCFierce
> GSK ($GSK) execs are talking up their $50 million "innovation" fund, which is bankrolling early-stage biotechs in the Quebec area. Story
> With its prospects for lorcaserin looking good these days, Arena Pharmaceuticals ($ARNA) says it will raise some extra cash through the sale of common stock. Report
> Gamida Cell has raised $10 million to back the launch of its lead cell therapy product. Report
> Pfizer ($PFE) says Torisel flunked a Phase III comparison study with Nexavar for renal cell carcinoma. Release
Pharma News
@FiercePharma: Patients 'waiting up to nine years' for NICE to approve drugs, a U.K. study finds--Telegraph. Story | Follow @FiercePharma
> Top 10 Best-selling Cancer Drugs in 2011. Special Report
> New discount persuades NICE to bless J&J's Zytiga. News
> U.K. report says NICE drags its feet on drug approvals. Article
Medical Device News
@FierceMedDev: Folks, the clock is ticking. Get your nominations in for the 15 fiercest device developers. Survey | Follow @FierceMedDev
> NeuroSigma buys patents that advance TFN stents. Report
> OraSure's OTC HIV test wins crucial FDA panel backing. Article
> Medtronic's Resolute Integrity stent gains CE mark for 7 new indications. More
> St. Jude wins CE mark for hypertension treatment device. Item
Drug Delivery News
@DamianFierce: Using self-assembling DNA tubes, Harvard researchers plan to effectively deliver drugs to cells. News | Follow @DamianFierce
> UNC researchers craft siRNA platform that can switch its solubility. Report
> MIT: Staggering cancer drugs can make them more effective. Story
> Japanese firm buys Altea's assets, plans to launch transdermal tech. Article
> D. Medical signs worldwide marketing deal for insulin-delivery tech. Item
Biomarkers News
> Genes tag schizophrenia risk. More
> Proteins in a drop of fluid mark osteoarthritis risk. Report
> Early pancreatic biomarker could spot killer disease. Article
> Gene IDs fast-onset Parkinson's disease. Story
And Finally… Investigators say they successfully slowed down the biological clock in mice in a proof of principle study that spurred expression of telomerase. Release